insights_auto
Pse është rritur NOTA 5,69%?
Zhytu më thellëchevron_right
NOTA:FRA
Novartis AG
130,00 €
arrow_upward
+5,69%(+7,00) 1D
7 tet, 2:25:21 m.d., GMT+2 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për NOTA...
Hap
122,00 €
I lartë
130,00 €
I ulët
122,00 €
Kapitalizimi i tregut
290,52Â mld
Vëllimi mesatar
27,00
Vëllimi
12,00
Maksimumi 52-javor
145,00 €
Minimumi 52-javor
102,50 €
Numri i punonjësve
75 mijë
Hap
122,00 €
I lartë
130,00 €
I ulët
122,00 €
Kapitalizimi i tregut
290,52Â mld
Vëllimi mesatar
27,00
Vëllimi
12,00
Maksimumi 52-javor
145,00 €
Minimumi 52-javor
102,50 €
Numri i punonjësve
75 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
AD HOC NEWS
·
3 orë më parë
Novartis stock draws a Hold consensus before Q3 results
Yahoo Finance
·
4 orë më parë
AI companies run virtual drug trials, aim to improve success of human studies
AD HOC NEWS
·
6 orë më parë
Novartis signs USD 7.8 billion deal. Novartis stock gains 1.87 percent.
AD HOC NEWS
·
8 orë më parë
Novartis stock pre-market at EUR 125.02: plus 0.33 percent
Profili
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Rreth Novartis AG
Drejtori ekzekutivVasant Narasimhan
Punonjësit75,3 mijë
Themeluar më7 mar 1996
SeliaBasel, Basel City, Zvicër
Sektori-
Uebsajtinovartis.com